Getting vaccinated more expensive?

LONDON: There is widespread research around the world for coronavirus vaccines. To this end, the whole world is focused on experiments conducted by Oxford University. However, it is doubtful how many people will get the vaccine when it is available. Professor Adrian Hill, one of the leading researchers on this, shared key points.

Hill said investigations are aimed at providing as many people as possible with the vaccine. If the experiments are successful, we will take steps to increase the production to reduce the demand to control the price. The research is aimed at making it cheaper and more inclusive. “This vaccine is costly. It is a single dose vaccine. Available to the Global Supply Chain. It is made in different places. This is our plan from the beginning, ”Hills explained. Already 10 lakh doses are ready .. All these will be available by September.

If there is trouble we will be there

The Oxford vaccine, named after the ‘ChAdOx1 nCoV-19’, now has worldwide hopes. The experiments on monkeys have already been promising. Hill predicted full results would be available by July or August. Responding to the results of the experiment on humans .. ” It is not fair to comment on the results during the launch. But you can understand that there are no frustrating issues so far, as experiments are still underway, ”he said.

Hill said seven manufacturing plants worldwide were capable of producing the ChAdOx1 vaccine. One of them is the serum institute in India. The company is actively involved in research with Oxford. More centers are located in China and Europe.